Organ Preservation Solution Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (University of Wisconsin Solution, Custodiol HTK, Perfadex, Hypothermosol, and Others), Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Type (Kidneys, Liver, Lungs, Heart, and Others), End User (Organ Transplant Centers, Hospitals, and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
The organ preservation solutions market size is expected to grow from US$ 274.41 million in 2023 to US$ 512.62 million by 2031; it is projected to register a CAGR of 8.2% during 2023-2031.
Transplantation surgeries are becoming more common worldwide. In 2023, the United Network for Organ Sharing reported a record of more than 46,000 organ transplants in the US, marking an increase of over 8.7% from 2022. Additionally, the country crossed the mark of 27,000 kidney transplants for the first time in its history. The Council of Europe reported that an average of 39,000 patients received an organ transplant, while 48,000 new patients (nearly 5 patients per hour) were added to waiting lists across its member states in 2022. Patients who are on the organ waiting list typically suffer from end-stage organ disease, which significantly affects their quality of life and may indicate that they are nearing the end of their life. The rising number of individuals with end-stage organ failure triggers the need for timely organ transplantation. Due to advancements in transplantation techniques, more such people are now eligible for organ transplants. Organ preservation solutions are used to maintain the viability and function of organs for a certain period, allowing for their transport and subsequent transplantation into a recipient. The success of organ transplantation is primarily determined by organ preservation, surgery, immunotherapy, and post-operative care. Thus, a rising demand for organ transplantation is a noteworthy factor contributing to the expansion of the organ preservation solutions market size.
However, the limited organ availability hinders the organ preservation solutions market growth as A huge gap exists between the number of organ donors and the patients who require an organ for transplantation. The limited number of donors for an organ is due to limited awareness, lack of family consent, religious beliefs, and misconceptions, among other factors. These factors restrict individuals from donating an organ to needy patients. In various countries across the world, sociocultural factors, beliefs and superstitions, insufficient communication and organizational support, and a negative perception play a pivotal role in holding people back from donating organs. These factors are more prevalent in countries in Asia Pacific. For instance, the concept of life after death is indirectly related to ethics, religion, and spirituality. Therefore, it becomes difficult to discuss organ donation in this region. The heart of a brain-dead person may continue to beat for the next 2–3 days if the body is kept on a ventilator. Moreover, vital organs such as the liver and kidney remain alive for the same period; thus, these organs can be surgically removed for donation. Thus, the inadequate availability of organs for transplantation hampers the growth of the organ preservation solutions market.
End User-Based InsightsBased on organ type, the organ preservation solutions market is segmented into heart, lung, kidney, liver, and others. The kidney segment held the largest share of the market in 2023 and is expected to register the highest CAGR in the market during 2023–2031. The demand for kidney transplantation procedures is likely to surge with the increasing incidence of kidney disease due to the high rate of renal failure. According to the Centers for Disease Control and Prevention (CDC) report published in 2021, more than 15% (1 in 7 or ~ 37 million) people in the US suffer from chronic kidney disease each year, with nearly 786,000 suffering from end-stage renal disease (ESRD). Various awareness campaigns are conducted to promote the benefits of kidney transplantation. For instance, in September 2022, the University Health Network's (UHN) Ajmera Transplant Centre announced the launch of a new campaign—Great Actions Leave a Mark—which showcased the stories and scars of 39 living organ donors and transplant recipients across Canada. The main aim of the campaign was to highlight the importance of organ donation in saving the lives of others and encourage the involvement of Canadians. Similarly, the NHS launched the Advancing American Kidney Health initiative with the objective of improving the lives of kidney disease patients in the US.
The International Registry On Organ Donation And Transplantation, University Health Network, and Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the organ preservation solutions market report.
Reasons to buySave and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the organ preservation solutions market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Organ Preservation Solutions market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution